The effect of yoga therapy consultations on symptom burden in inpatient cancer care: a retrospective observational study
摘要
Extended hospitalization can lead to fatigue, sleep disturbance, anxiety, depression, and functional decline in cancer patients. This retrospective observational study examined reasons for referral to inpatient one-on-one Yoga Therapy (YT) consultations and observed the delivery of YT to address symptoms. Exploratory analyses examined patient-reported outcomes (PROs) following a single YT session.
MethodsData from inpatient YT consultations from January 2020 to March 2023 were evaluated. Information included demographics, referral reason, and self-reported symptom burden before and after YT using the modified Edmonton Symptom Assessment Scale (mESAS). Changes in mESAS scores were evaluated by the Wilcoxon signed-rank test.
ResultsPre-post mESAS responses were available for 88/130 YT referrals. Most patients were female (n = 88; 67.7%) and white (n = 101; 77.7%), with a mean age of 53.1. The most common cancer diagnosis was leukemia (19.2%), and 40.8% had metastatic disease. The primary referral reasons were fatigue (76.9%), anxiety/stress reduction (76.2%), and quality of life (62.3%). The highest patient-reported symptoms pre-YT were Fatigue (x ̅ = 5.26), decreased Well-Being (x ̅ = 4.89), and Sleep disturbances (x ̅4.66). Following YT, participants reported clinically and statistically significant reductions in Fatigue (mean difference (MD) = -1.62, p < 0.001, ES = 0.82), Anxiety (MD = -1.56, p < 0.001, ES = 0.78), and Pain (MD = 1.44, p < 0.001, ES = 0.79), with significant reductions in mESAS components except Financial Distress and Spiritual Pain. Change scores were larger for patients scoring ≥ 4 on a specific symptom pre-YT.
ConclusionsFindings suggested that a single inpatient YT intervention provided immediate relief from symptom burden, especially for those reporting high symptom burden. The long-term effects of inpatient YT merits further study as a non-pharmacologic intervention to reduce symptom burden in patients with cancer.